The Mounjaro NHS Deal — and What It Means If You're Paying Privately

What the NHS rollout actually offers, and who qualifies now

NICE recommended tirzepatide for NHS use in December 2024 (TA1026), but the rollout is deliberately phased. As of summer 2026, NHS access requires a BMI of 40 or above plus four or more of a defined list of weight-related conditions, high blood pressure, dyslipidaemia, obstructive sleep apnoea, cardiovascular disease, or type 2 diabetes. A second cohort covering BMI 35–39.9 with the same four-condition threshold activated in June 2026. Thresholds are set 2.5 kg/m² lower for some ethnic backgrounds under UK guidance. Even patients who clear those hurdles must enrol in wraparound dietary and activity support; meeting the criteria on paper is not the same as being offered treatment tomorrow. For the full eligibility picture on the NHS pathway, this page on NHS Mounjaro access sets it out clearly.

GP practices have been able to prescribe under the new contract since April 2026, but participation varies by practice and area. If you want to understand what the NHS actually charges for this treatment, our page on Mounjaro NHS cost breaks down what patients can expect to pay through that route. The honest position for most people who search for an 'NHS Mounjaro deal' is that they either don't yet qualify or would face a wait with no guaranteed timeline. Private prescription, through a pharmacy you can verify, is the practical alternative. Our Mounjaro overview explains the full licensed picture if you want the clinical context first.

How private Mounjaro pricing actually works, and what headline figures leave out

Since Eli Lilly revised its UK list price in September 2025, the market for private tirzepatide has restated itself. Reported private prices since then range roughly £149 to £375 per four-week pen depending on dose and provider, though those figures should be treated as indicative, the market moves. Current Mounjaro pricing context covers how these figures break down across doses.

What matters more than the headline figure is what it includes. Many providers charge separately for the initial consultation, the prescription itself, and delivery. Some bill for clinical reviews at each dose increase or for aftercare calls. A £149 listing that excludes three of those things is not necessarily cheaper than a higher number that bundles them all. Before comparing providers, it is worth asking: what happens if I need to discuss a side effect on a Saturday? Is the consultation fee added at checkout? Is repeat clinical review included or priced per contact?

If you want to see how providers stack up on cost, our guide to the cheapest Mounjaro pens explains what drives price differences and what to watch out for when comparing options. If you're looking at spread-payment options for Mounjaro, the same principle applies, the total cost over a treatment course is the honest comparison, not the weekly figure in isolation.

Where nume stands, and why we're transparent about not being cheapest

We set out to be the service we'd want a family member to use, not the one with the lowest number on a price-comparison page. Every order through nume covers consultation, prescription, the treatment, and free next-working-day DPD delivery to your door in plain, unbranded packaging. Aftercare is available seven days a week. There are no subscription contracts and no auto-renewals, each repeat is clinically reviewed before it goes anywhere near dispatch. The current treatment price is shown on our treatment page; we don't print per-pen figures in our content because those numbers age faster than the page does.

We don't run discount codes, vouchers, or promotional deals for prescription medicines. That's a deliberate position. If you've come across something advertised as a Mounjaro deal, it is worth pausing to verify who is actually behind it, because a code that takes money off a prescription-only medicine from a seller you can't verify is a warning sign, not a bargain. The MHRA has seized counterfeit tirzepatide pens from an illicit UK manufacturing operation and repeatedly warned about fake weight-loss injections sold online. If you're weighing up providers, the GPhC pharmacy register at pharmacyregulation.org lets you check whether a pharmacy is properly registered. Ours is: GPhC registration 9012878.

A useful frame: the pen sits in the fridge like any other medicine, it doesn't know how much you paid for it. What matters is that it's genuine, correctly stored, and prescribed after someone who is actually qualified looked at your medical history.

For a prescription medicine, price isn't the right test, here's what is

Mounjaro is a Prescription-Only Medicine. A prescriber reviews your history, your current medicines, your weight, and your goals before deciding whether it's appropriate and at what dose. That clinical layer is not an administrative formality, it's what makes the treatment safe. A service that skips it, or buries it in small print, is not offering you a deal; it is shifting risk onto you.

The right questions are whether the pharmacy is GPhC-registered, whether a named clinician reviews your case, whether genuine supply-chain stock is being dispensed, and whether there's someone medically qualified to call if something doesn't feel right. How we work covers each of those points if you want to check. Our clinical team's approach to prescribing is outlined on this page. If you have general questions before starting, including what you'd pay through the NHS compared with a private provider, our page on Mounjaro NHS price is a useful reference alongside our FAQs, which address the questions we hear most often.

When you're ready to find out whether Mounjaro is clinically appropriate for you, the place to start is a free consultation, no commitment, no cost, no algorithm making the call.

Check your eligibility with a free consultation.